Literature DB >> 23543545

Interventions to improve professional adherence to guidelines for prevention of device-related infections.

Gerd Flodgren1, Lucieni O Conterno, Alain Mayhew, Omar Omar, Cresio Romeu Pereira, Sasha Shepperd.   

Abstract

BACKGROUND: Healthcare-associated infections (HAIs) are a major threat to patient safety, and are associated with mortality rates varying from 5% to 35%. Important risk factors associated with HAIs are the use of invasive medical devices (e.g. central lines, urinary catheters and mechanical ventilators), and poor staff adherence to infection prevention practices during insertion and care for the devices when in place. There are specific risk profiles for each device, but in general, the breakdown of aseptic technique during insertion and care for the device, as well as the duration of device use, are important factors for the development of these serious and costly infections.
OBJECTIVES: To assess the effectiveness of different interventions, alone or in combination, which target healthcare professionals or healthcare organisations to improve professional adherence to infection control guidelines on device-related infection rates and measures of adherence. SEARCH
METHODS: We searched the following electronic databases for primary studies up to June 2012: the Cochrane Effective Paractice and Organisation of Care (EPOC) Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL. We searched reference lists and contacted authors of included studies. We also searched the Cochrane Database of Systematic Reviews and Database of Abstracts of Reviews of Effectiveness (DARE) for related reviews. SELECTION CRITERIA: We included randomised controlled trials (RCTs), non-randomised controlled trials (NRCTs), controlled before-after (CBA) studies and interrupted time series (ITS) studies that complied with the Cochrane EPOC Group methodological criteria, and that evaluated interventions to improve professional adherence to guidelines for the prevention of device-related infections. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and assessed the risk of bias of each included study using the Cochrane EPOC 'Risk of bias' tool. We contacted authors of original papers to obtain missing information. MAIN
RESULTS: We included 13 studies: one cluster randomised controlled trial (CRCT) and 12 ITS studies, involving 40 hospitals, 51 intensive care units (ICUs), 27 wards, and more than 3504 patients and 1406 healthcare professionals. Six of the included studies targeted adherence to guidelines to prevent central line-associated blood stream infections (CLABSIs); another six studies targeted adherence to guidelines to prevent ventilator-associated pneumonia (VAP), and one study focused on interventions to improve urinary catheter practices. We judged all included studies to be at moderate or high risk of bias.The largest median effect on rates of VAP was found at nine months follow-up with a decrease of 7.36 (-10.82 to 3.14) cases per 1000 ventilator days (five studies and 15 sites). The one included cluster randomised controlled trial (CRCT) observed, improved urinary catheter practices five weeks after the intervention (absolute difference 12.2 percentage points), however, the statistical significance of this is unknown given a unit of analysis error. It is worth noting that N = 6 interventions that did result in significantly decreased infection rates involved more than one active intervention, which in some cases, was repeatedly administered over time, and further, that one intervention involving specialised oral care personnel showed the largest step change (-22.9 cases per 1000 ventilator days (standard error (SE) 4.0), and also the largest slope change (-6.45 cases per 1000 ventilator days (SE 1.42, P = 0.002)) among the included studies. We attempted to combine the results for studies targeting the same indwelling medical device (central line catheters or mechanical ventilators) and reporting the same outcomes (CLABSI and VAP rate) in two separate meta-analyses, but due to very high statistical heterogeneity among included studies (I(2) up to 97%), we did not retain these analyses. Six of the included studies reported post-intervention adherence scores ranging from 14% to 98%. The effect on rates of infection were mixed and the effect sizes were small, with the largest median effect for the change in level (interquartile range (IQR)) for the six CLABSI studies being observed at three months follow-up was a decrease of 0.6 (-2.74 to 0.28) cases per 1000 central line days (six studies and 36 sites). This change was not sustained over longer follow-up times. AUTHORS'
CONCLUSIONS: The low to very low quality of the evidence of studies included in this review provides insufficient evidence to determine with certainty which interventions are most effective in changing professional behaviour and in what contexts. However, interventions that may be worth further study are educational interventions involving more than one active element and that are repeatedly administered over time, and interventions employing specialised personnel, who are focused on an aspect of care that is supported by evidence e.g. dentists/dental auxiliaries performing oral care for VAP prevention.

Entities:  

Mesh:

Year:  2013        PMID: 23543545     DOI: 10.1002/14651858.CD006559.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  40 in total

1.  A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria.

Authors:  Luigi Segagni Lusignani; Alexander Blacky; Peter Starzengruber; Magda Diab-Elschahawi; Thomas Wrba; Elisabeth Presterl
Journal:  Wien Klin Wochenschr       Date:  2016-01-27       Impact factor: 1.704

2.  A Cautionary Tale on the Central Venous Catheter: Medical Note for Oral Physicians.

Authors:  Ramasamy Chidambaram
Journal:  Malays J Med Sci       Date:  2015-09

3.  Checking rounds for isolation precautions in the control of multidrug-resistant organisms: reduction achieved.

Authors:  P Barbadoro; E Martini; M G Gioia; R Stoico; S Savini; E Manso; G Serafini; E Prospero; M M D'Errico
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-07       Impact factor: 3.267

4.  Bringing central line-associated bloodstream infection prevention home: catheter maintenance practices and beliefs of pediatric oncology patients and families.

Authors:  Michael L Rinke; Allen R Chen; Aaron M Milstone; Lindsay C Hebert; David G Bundy; Elizabeth Colantuoni; Lisa Fratino; Cynthia Herpst; Michelle Kokoszka; Marlene R Miller
Journal:  Jt Comm J Qual Patient Saf       Date:  2015-04

Review 5.  Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis.

Authors:  Koen Blot; Jochen Bergs; Dirk Vogelaers; Stijn Blot; Dominique Vandijck
Journal:  Clin Infect Dis       Date:  2014-04-09       Impact factor: 9.079

Review 6.  An Ounce of Prevention Saves Tons of Lives: Infection in Burns.

Authors:  Nishant Merchant; Karen Smith; Marc G Jeschke
Journal:  Surg Infect (Larchmt)       Date:  2015-06-02       Impact factor: 2.150

Review 7.  Implantable Device-Related Infection.

Authors:  J Scott VanEpps; John G Younger
Journal:  Shock       Date:  2016-12       Impact factor: 3.454

8.  Staff Knowledge, Awareness, Perceptions, and Beliefs About Infection Prevention in Pediatric Long-term Care Facilities.

Authors:  Borghild Løyland; Sibyl Wilmont; Amanda J Hessels; Elaine Larson
Journal:  Nurs Res       Date:  2016 Mar-Apr       Impact factor: 2.381

Review 9.  Default options in the ICU: widely used but insufficiently understood.

Authors:  Joanna Hart; Scott D Halpern
Journal:  Curr Opin Crit Care       Date:  2014-12       Impact factor: 3.687

Review 10.  Economic Evaluation of Quality Improvement Interventions for Bloodstream Infections Related to Central Catheters: A Systematic Review.

Authors:  Teryl K Nuckols; Emmett Keeler; Sally C Morton; Laura Anderson; Brian Doyle; Marika Booth; Roberta Shanman; Jonathan Grein; Paul Shekelle
Journal:  JAMA Intern Med       Date:  2016-12-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.